drugset / Trial / NCT05497492

Comparison of the Effects of Esketamine, Sufentanil, or Lidocaine on Tussis Reflection During Upper Gastroscopy

NCT05497492

RandomizedParallel-groupTriple-blindPrevention

Summary

the frequency of tussis, nausea and vomiting, and/or body movements observed at the insertion of the endoscope into the pharyngeal cavity or within 5 min of endoscope insertion.

Timeline

Start
2022-11-05
Primary completion
2023-12-30
Completion
2023-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 1.5 mg/ml Intravenous
Subject Lidocaine Other / unclassified 10 mg/ml Intravenous
Comparator Propofol Small molecule 1.5 mg/kg Intravenous
Subject Sufentanil Other / unclassified 0.5 ug/ml Intravenous

Indications

No indication recorded.